| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M Hansenn. [The p300 cognitive event-related potential. I. Theoretical and psychobiologic perspectives]. Neurophysiologie clinique = Clinical neurophysiology. vol 30. issue 4. 2000-10-19. PMID:11013894. |
psychopharmacological studies have shown that different neurotransmitter systems are involved in the generation and modulation of p300, namely the cholinergic, noradrenergic, dopaminergic, serotoninergic and gabaergic systems. |
2000-10-19 |
2023-08-12 |
human |
| J M Rumsey, M Erns. Functional neuroimaging of autistic disorders. Mental retardation and developmental disabilities research reviews. vol 6. issue 3. 2000-10-16. PMID:10982494. |
neurotransmitter studies using positron emission tomography (pet) suggest abnormalities of serotonergic and dopaminergic function. |
2000-10-16 |
2023-08-12 |
human |
| G P Galloway, S L Frederick-Osborne, R Seymour, S E Contini, D E Smit. Abuse and therapeutic potential of gamma-hydroxybutyric acid. Alcohol (Fayetteville, N.Y.). vol 20. issue 3. 2000-08-11. PMID:10869868. |
gamma-hydroxybutyric acid effects dopaminergic systems in the brain and may be a neurotransmitter. |
2000-08-11 |
2023-08-12 |
human |
| A G Sanz, A Badia, M V Clo. Role of calcium on the modulation of spontaneous acetylcholine efflux by the D2 dopamine receptor subtype in rat striatal synaptosomes. Brain research. vol 854. issue 1-2. 2000-07-27. PMID:10784105. |
although 1 microm of 7-hydroxy-n,n-di-n-propyl-2-aminotetraline (7-oh-dpat) inhibited spontaneous [3h]ach efflux in the presence of calcium, this dopaminergic agonist did not modify the neurotransmitter release in either the low-ca2+ medium or in the presence of vesamicol. |
2000-07-27 |
2023-08-12 |
rat |
| P Teismann, B Ferge. Comparison of the novel drug Ensaculin with MK-801 on the reduction of hydroxyl radical production in rat striatum after local application of glutamate. Brain research. vol 857. issue 1-2. 2000-05-04. PMID:10700564. |
ensaculin interacts with various neurotransmitter systems (e.g., dopaminergic, serotoninergic, glutamatergic) and was originally designed for the treatment of dementia. |
2000-05-04 |
2023-08-12 |
rat |
| T H Rammsayer, S Rodewald, D Gro. Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions. Brain research. Cognitive brain research. vol 9. issue 1. 2000-04-11. PMID:10666558. |
the overall pattern of results revealed that memory processes are much more susceptible to changes in gabaergic than in dopaminergic or cholinergic neurotransmitter activity. |
2000-04-11 |
2023-08-12 |
human |
| T H Rammsayer, S Rodewald, D Gro. Dopamine-antagonistic, anticholinergic, and GABAergic effects on declarative and procedural memory functions. Brain research. Cognitive brain research. vol 9. issue 1. 2000-04-11. PMID:10666558. |
furthermore, the present findings point to the conclusion that the modulating effects of dopaminergic, gabaergic, and cholinergic neurotransmitter systems on declarative and procedural memory functions are less specific than suggested by neuropsychological studies in patients. |
2000-04-11 |
2023-08-12 |
human |
| J Hennig, C Toll, P Schonlau, S Rohrmann, P Nette. Endocrine responses after d-fenfluramine and ipsapirone challenge: further support for Cloninger's tridimensional model of personality. Neuropsychobiology. vol 41. issue 1. 2000-03-21. PMID:10629434. |
the tridemensional model of personality introduced by cloninger relates aspects of novelty seeking to the dopaminergic, harm avoidance (ha) to the serotonergic, and reward dependence to the noradrenergic neurotransmitter system. |
2000-03-21 |
2023-08-12 |
human |
| R Schlösse. [Detection of neurotransmitter interactions with PET and SPECT by pharmacological challenge paradigms]. Der Nervenarzt. vol 71. issue 1. 2000-03-21. PMID:10695027. |
especially, interactions of different neurotransmitter systems with the dopaminergic and the cholinergic system will be discussed. |
2000-03-21 |
2023-08-12 |
human |
| A Serretti, F Benedetti, C Colombo, R Lilli, C Lorenzi, E Smerald. Dopamine receptor D4 is not associated with antidepressant activity of sleep deprivation. Psychiatry research. vol 89. issue 2. 2000-02-08. PMID:10646829. |
total sleep deprivation (tsd) is an effective treatment for mood disorders which is thought to act through an enhancement in several neurotransmitter pathways including dopaminergic transmission. |
2000-02-08 |
2023-08-12 |
Not clear |
| R Lints, S W Emmon. Patterning of dopaminergic neurotransmitter identity among Caenorhabditis elegans ray sensory neurons by a TGFbeta family signaling pathway and a Hox gene. Development (Cambridge, England). vol 126. issue 24. 2000-01-21. PMID:10572056. |
patterning of dopaminergic neurotransmitter identity among caenorhabditis elegans ray sensory neurons by a tgfbeta family signaling pathway and a hox gene. |
2000-01-21 |
2023-08-12 |
caenorhabditis_elegans |
| P T Trzepac. Update on the neuropathogenesis of delirium. Dementia and geriatric cognitive disorders. vol 10. issue 5. 1999-11-18. PMID:10473933. |
an imbalance in the cholinergic and dopaminergic neurotransmitter systems is most commonly implicated in causing delirium, and could both account for delirium symptoms and be consistent with the neuroanatomical pathways being implicated. |
1999-11-18 |
2023-08-12 |
Not clear |
| J S Baffi, M Palkovits, S O Castillo, E Mezey, V M Nikode. Differential expression of tyrosine hydroxylase in catecholaminergic neurons of neonatal wild-type and Nurr1-deficient mice. Neuroscience. vol 93. issue 2. 1999-10-07. PMID:10465447. |
subsequent analysis revealed the absence of neurotransmitter dopamine and tyrosine hydroxylase immunoreactivity in the central dopaminergic area of newborn pups. |
1999-10-07 |
2023-08-12 |
mouse |
| S Rahman, T W Robbins, B J Sahakia. Comparative cognitive neuropsychological studies of frontal lobe function: implications for therapeutic strategies in frontal variant frontotemporal dementia. Dementia and geriatric cognitive disorders. vol 10 Suppl 1. 1999-10-01. PMID:10436335. |
finally, we evaluate critically the rationales for therapeutic modulation of noradrenergic, serotonergic and dopaminergic neurotransmitter systems at various stages of disease. |
1999-10-01 |
2023-08-12 |
Not clear |
| P S Goldman-Raki. The "psychic" neuron of the cerebral cortex. Annals of the New York Academy of Sciences. vol 868. 1999-08-12. PMID:10414278. |
i will describe the dopaminergic, serotonergic, and gabaergic innervation of pyramidal neurons engaged in working memory and the localization of neurotransmitter receptors through which they exert their actions. |
1999-08-12 |
2023-08-12 |
human |
| J Thome, H G Weijers, G A Wiesbeck, J Sian, K Nara, J Böning, P Riedere. Dopamine D3 receptor gene polymorphism and alcohol dependence: relation to personality rating. Psychiatric genetics. vol 9. issue 1. 1999-07-20. PMID:10335548. |
thus, the genetics of the dopaminergic neurotransmitter system alone cannot explain the aetiopathogenesis of alcoholism. |
1999-07-20 |
2023-08-12 |
Not clear |
| M Vila, C Marin, M Ruberg, A Jimenez, R Raisman-Vozari, Y Agid, E Tolosa, E C Hirsc. Systemic administration of NMDA and AMPA receptor antagonists reverses the neurochemical changes induced by nigrostriatal denervation in basal ganglia. Journal of neurochemistry. vol 73. issue 1. 1999-07-08. PMID:10386987. |
because the subthalamic nucleus uses glutamate as neurotransmitter and is innervated by glutamatergic fibers, pharmacological blockade of glutamate transmission might be expected to restore the cascade of neurochemical changes induced by a dopaminergic denervation within the basal ganglia. |
1999-07-08 |
2023-08-12 |
rat |
| K S Sugamori, F J Lee, Z B Pristupa, H B Nizni. A cognate dopamine transporter-like activity endogenously expressed in a COS-7 kidney-derived cell line. FEBS letters. vol 451. issue 2. 1999-07-06. PMID:10371159. |
estimated ki values of numerous substrates and inhibitors for the cos-dopamine transporter and the cloned human neuronal transporter (human dopamine transporter) correlate well with the exception of a few notable compounds, including the endogenous neurotransmitter dopamine, the dopamine transporter inhibitor gbr 12,909 and the dopaminergic agonist apomorphine. |
1999-07-06 |
2023-08-12 |
human |
| A Inoue, Y Nakat. [How do antipsychotics exert their effects on dopamine receptor subtypes?]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. vol 112. issue 6. 1999-05-17. PMID:10202760. |
recent evidences from studies on the effects of novel antipsychotic drugs such as clozapine on neurotransmitter receptors are prompting reconsideration of the dopaminergic hypothesis of schizophrenia. |
1999-05-17 |
2023-08-12 |
rat |
| T Ma, H H Chen, I K H. Effects of chronic lead (Pb) exposure on neurobehavioral function and dopaminergic neurotransmitter receptors in rats. Toxicology letters. vol 105. issue 2. 1999-05-07. PMID:10221273. |
effects of chronic lead (pb) exposure on neurobehavioral function and dopaminergic neurotransmitter receptors in rats. |
1999-05-07 |
2023-08-12 |
rat |